Form 4/A for GANX Gain Therapeutics, Inc.
Accepted 2022-05-23 00:00:00 ET · period of report 2022-05-19 · accession 0001415889-22-005491 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-05-23 | 2022-05-19 | GANX | Calabrese Salvatore | CFO | P - Purchase | $2.70 | +3,000 | 3,000 | New | +$8,100 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-19 | P | A | 3,000 | $2.70 | 3,000 | D | — | — |